08-05-2021 04:03 PM | Source: Reuters
India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
BENGALURU - India's Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID-19 vaccine using the drug substance made by Russia's Generium.
Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories for distribution in India. (https://bit.ly/3joeloz)
Latest News
Blue Star`s FY24 Total Income rises 21.4% to Rs 9685...
Indian shares log gains on less-hawkish Fed, easing ...
Post market comment by Mandar Bhojane, Research Anal...
Adani Enterprises Ltd posts robust FY24 results, inc...
Daily Market Analysis : Trading in the markets remai...
India's Vodafone Idea in talks to avail loans worth ...
Godrej Security Solutions Partners with HDFC Bank to...
Groww launches India`s first Nifty Non-Cyclical Cons...
Federal Bank climbs on reporting rise in Q4 consolid...
Eicher Motors inches up after its motorcycle divisio...
